• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增殖细胞核抗原(PCNA);在原发性基底细胞癌临床复发中的预后价值。

Proliferating cell nuclear antigen (PCNA); prognostic value in the clinical recurrence of primary basal cell carcinoma.

作者信息

Toth D P, Guenther L C, Shum D T

机构信息

Division of Dermatology, Victoria Hospital, University of Western Ontario, London, Canada.

出版信息

J Dermatol Sci. 1996 Jan;11(1):36-40. doi: 10.1016/0923-1811(95)00417-3.

DOI:10.1016/0923-1811(95)00417-3
PMID:8867765
Abstract

Proliferating cell nuclear antigen (PCNA) is a nuclear protein which is correlated with the S-phase of the cell cycle and has been utilized by many investigators as a marker of cell proliferation. A previous immunohistochemical study revealed increased PCNA staining in clinically and histologically aggressive basal cell carcinoma and the present study evaluated the prognostic value of PCNA in clinical recurrence of primary basal cell carcinoma. Thirty patients with primary basal cell carcinoma (BCC) treated with shave biopsy followed by electrodesiccation in 1989 and have been regularly followed up for local recurrence were selected for this study. The histology of their primary BCC's was reviewed and the presence of PCNA in the tumor cells was studied immunohistochemically. Ninety-six percent of the non-recurrent BCC's had < 10% of tumor cells showing a positive staining for PCNA whereas 100% of the BCC's that recurred showed more than 30% of tumor cells staining positive for PCNA. In comparison, 88.9% of the non-recurring group showed non-aggressive histological features and only 66.7% of the recurring group was aggressive by microscopic appearance. In summary, the PCNA staining appeared to be superior to traditional histologic features in predicting clinical recurrence in primary BCC's and further prospective studies in a larger patient group are warranted.

摘要

增殖细胞核抗原(PCNA)是一种核蛋白,与细胞周期的S期相关,许多研究人员将其用作细胞增殖的标志物。先前的一项免疫组织化学研究显示,在临床和组织学上侵袭性的基底细胞癌中PCNA染色增加,本研究评估了PCNA在原发性基底细胞癌临床复发中的预后价值。本研究选取了30例1989年接受剃除活检继以电干燥治疗的原发性基底细胞癌(BCC)患者,这些患者一直在定期随访局部复发情况。回顾了他们原发性BCC的组织学,并通过免疫组织化学研究了肿瘤细胞中PCNA的存在情况。96%的未复发BCC中,<10%的肿瘤细胞PCNA染色呈阳性,而100%复发的BCC中,超过30%的肿瘤细胞PCNA染色呈阳性。相比之下,88.9%的未复发组表现出非侵袭性组织学特征,而复发组中只有66.7%在显微镜下表现为侵袭性。总之,在预测原发性BCC的临床复发方面,PCNA染色似乎优于传统组织学特征,有必要在更大的患者群体中进行进一步的前瞻性研究。

相似文献

1
Proliferating cell nuclear antigen (PCNA); prognostic value in the clinical recurrence of primary basal cell carcinoma.增殖细胞核抗原(PCNA);在原发性基底细胞癌临床复发中的预后价值。
J Dermatol Sci. 1996 Jan;11(1):36-40. doi: 10.1016/0923-1811(95)00417-3.
2
Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.基底细胞癌不同组织学变体中p53、增殖细胞核抗原(PCNA)和Ki-67的免疫组织化学细胞核染色
J Am Acad Dermatol. 1997 Sep;37(3 Pt 1):430-7. doi: 10.1016/s0190-9622(97)70145-2.
3
Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.基底细胞癌不同组织学变体中p53、增殖细胞核抗原(PCNA)、Ki-67和bcl-2的免疫组织化学细胞核染色
Rom J Morphol Embryol. 2011;52(1 Suppl):315-9.
4
Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.膀胱移行细胞癌中增殖细胞核抗原、p53蛋白和nm23蛋白的免疫组织化学分析及核DNA含量分析
Cancer. 1996 Oct 15;78(8):1762-74. doi: 10.1002/(sici)1097-0142(19961015)78:8<1762::aid-cncr17>3.0.co;2-w.
5
Evaluation of proliferating cell nuclear antigen as a surrogate end point biomarker in actinic keratosis and adjacent, normal-appearing, and non-sun-exposed human skin samples.增殖细胞核抗原作为光化性角化病及相邻正常外观和非阳光暴露的人体皮肤样本替代终点生物标志物的评估。
Cancer Epidemiol Biomarkers Prev. 1996 May;5(5):343-8.
6
Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.口腔鳞状细胞癌侵袭前沿的 p53 和 PCNA 表达形式:与临床病理特征和预后的相关性。
J Oral Pathol Med. 2011 Oct;40(9):693-8. doi: 10.1111/j.1600-0714.2011.01032.x. Epub 2011 Apr 18.
7
Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.使用Bcl-2、Ki67、增殖细胞核抗原(PCNA)和P53对基底细胞癌和毛发上皮瘤进行免疫组织化学评估。
J Cutan Pathol. 2000 Apr;27(4):169-75. doi: 10.1034/j.1600-0560.2000.027004169.x.
8
Immunohistochemical study of primary and recurrent basal cell and metatypical carcinomas of the skin.
Am J Dermatopathol. 1996 Feb;18(1):35-42. doi: 10.1097/00000372-199602000-00006.
9
Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma.
J Neurosurg. 1996 Jan;84(1):85-90. doi: 10.3171/jns.1996.84.1.0085.
10
Proliferating cell nuclear antigen and grade of malignancy in small hepatocellular carcinoma--evaluation in US-guided specimens.
Hepatogastroenterology. 1997 Jan-Feb;44(13):245-50.

引用本文的文献

1
Dose-response on the chemopreventive effects of sarcophine-diol on UVB-induced skin tumor development in SKH-1 hairless mice. sarcophine-diol 对 UVB 诱导的 SKH-1 无毛小鼠皮肤肿瘤发生的化学预防作用的剂量反应。
Mar Drugs. 2012 Sep;10(9):2111-2125. doi: 10.3390/md10092111. Epub 2012 Sep 24.
2
Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice.鸟氨酸脱羧酶是Ptch1+/-小鼠基底细胞癌和鳞状细胞癌化学预防的靶点。
J Clin Invest. 2004 Mar;113(6):867-75. doi: 10.1172/JCI20732.